Latest filing published 09 Mar 2020 for GlaxoSmithKline plc, €60k.
Insider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
C J Conrad: trading record in brief
All filings by C J Conrad on record concern GlaxoSmithKline plc. Between 30 August 2019 and 5 March 2020, the trades on record add up to 2 filings.
Every open-market trade on record is a purchase: 2 purchases worth €128k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2020 alone, the filings show 1 purchase and no sales.
Most recently, on 9 March 2020, the filings show an open-market purchase worth €60k in GlaxoSmithKline plc. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to C J Conrad
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,570 shares@ US$42.53100.0% of flowNew York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:LSE20200309161547_3520223_20200331164956063_8912-1Canonical exit: 3 Jun 2020 (T+90)
- 1,800 shares@ US$41.7553.1% of flowNew York Stock Exchange (XNYS)ISIN US37733W1053FCA-NSM:LSE20190904093333_14213391_20200326185205254_39019-1Canonical exit: 28 Nov 2019 (T+90)
2 of 0 declarations